Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis
- PMID: 28008457
- DOI: 10.1007/s00296-016-3632-y
Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis
Abstract
The aim of this study was to estimate prevalence and severity of renal insufficiency in systemic sclerosis (SSc) and to assess risk factors associated with reduced glomerular filtration rate (GFR) in SSc patients. Seventy-three consecutive patients with SSc (67 women and 6 men), mean age 56.2 years, mean disease duration 6.7 years, were included in this cross-sectional study. GFR was measured by creatinine clearance (CCr) in all patients, as well as 24-h proteinuria. We assessed frequency and severity of renal insufficiency in our patients with SSc and estimated the association of renal insufficiency with age, disease duration, subtype of the disease, earlier diagnosed arterial hypertension, and medications for which we assumed to affect renal function-cytostatics, nonsteroidal anti-inflammatory drugs, glucocorticoids, ACE inhibitors, diuretics, and calcium channel blockers (CCB). Fifty-six out of 73 patients with SSc (76.7%) had reduced GFR (CCr lower than 90 ml/min), compared to 17/73 (23.3%) of patients with normal renal function. Mild renal insufficiency was noticed in 28/73 (38.4%), moderate in 21/73 (28.8%) and severe renal insufficiency in 5/73 (6.8%). End-stage renal disease (CCr < 15 ml/min) was found in 2/73 (2.7%) of patients. Using the univariate general linear statistical model, we have found that previously diagnosed arterial hypertension and treatment with glucocorticoids are independent risk factors for reduced GFR. On the other hand, age, disease duration, disease form, as well as antibodies (anticentromere antibodies-ACA and anti-topoisomerase I antibodies-ATA) were excluded as independent risk factors. Patients with SSc and arterial hypertension treated with CCB had significantly higher mean CCr than patients treated with diuretics (90.4 vs 53.5 ml/min, p = 0.03), or patients treated with ACE inhibitors (90.4 vs 41.7 ml/min, p = 0.001). Decreased GFR is common in SSc. Most of patients have mild or moderate renal insufficiency. Previously diagnosed arterial hypertension, especially when treated with ACE inhibitors or diuretics, and glucocorticoids are independent risk factors associated with reduced GFR in SSc. These medications should be therefore used with caution in SSc patients.
Keywords: Renal insufficiency; Risk factors; Systemic sclerosis.
Similar articles
-
Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?J Am Geriatr Soc. 2002 Jul;50(7):1297-300. doi: 10.1046/j.1532-5415.2002.50321.x. J Am Geriatr Soc. 2002. PMID: 12133029
-
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936. Arch Intern Med. 2005. PMID: 15851647 Clinical Trial.
-
Renal function is mostly preserved in patients with systemic sclerosis.Scand J Rheumatol. 2009;38(4):295-8. doi: 10.1080/03009740802629424. Scand J Rheumatol. 2009. PMID: 19214870
-
Scleroderma Renal Crisis.Rheum Dis Clin North Am. 2015 Aug;41(3):475-88. doi: 10.1016/j.rdc.2015.04.008. Epub 2015 May 26. Rheum Dis Clin North Am. 2015. PMID: 26210130 Review.
-
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.J Nephrol. 2002 Jul-Aug;15(4):428-30. J Nephrol. 2002. PMID: 12243375 Review.
Cited by
-
Arterial hypertension in systemic sclerosis.Postepy Dermatol Alergol. 2022 Oct;39(5):865-871. doi: 10.5114/ada.2022.120881. Epub 2022 Nov 9. Postepy Dermatol Alergol. 2022. PMID: 36457666 Free PMC article.
-
Role of Inflammatory Diseases in Hypertension.High Blood Press Cardiovasc Prev. 2017 Dec;24(4):353-361. doi: 10.1007/s40292-017-0214-3. Epub 2017 Jun 9. High Blood Press Cardiovasc Prev. 2017. PMID: 28597352 Review.
-
A risk scoring system for the decreased glomerular filtration rate in Chinese general population.J Clin Lab Anal. 2020 Apr;34(4):e23143. doi: 10.1002/jcla.23143. Epub 2019 Dec 22. J Clin Lab Anal. 2020. PMID: 31867757 Free PMC article.
-
Trigonelline reverses high glucose-induced proliferation, fibrosis of mesangial cells via modulation of Wnt signaling pathway.Diabetol Metab Syndr. 2022 Feb 9;14(1):28. doi: 10.1186/s13098-022-00798-w. Diabetol Metab Syndr. 2022. PMID: 35139912 Free PMC article.
-
Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.Nat Rev Cardiol. 2018 Jan;15(1):33-44. doi: 10.1038/nrcardio.2017.118. Epub 2017 Aug 24. Nat Rev Cardiol. 2018. PMID: 28836617 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous